Abstract: The present invention is directed to plasmalogens and pharmaceutical compositions thereof which are useful for treating neurodegenerative diseases. Carbons 1 and 2 of the phosphoglyceryl backbone of the plasmaolgens have from 10-24 carbon atoms containing from 1 to 6 double bonds. The phosphoryl group is bonded to choline, ethanolamine, serine or inositol.
Type:
Grant
Filed:
March 4, 1997
Date of Patent:
June 2, 1998
Assignee:
S.AR.L. Institut d'Hygiene et Dietetique